MiR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal transition by targeting KRAS in renal cell carcinoma cells

DNA and Cell Biology

Volumn 34, Issue 6, 2015, Pages 429-436

  Liu, Yiyang ^a   Zhang, Mingcong ^a   Qian, Jian ^a   Bao, Meiling ^a   Meng, Xiaoxin ^a   Zhang, Shaobo ^a   Zhang, Lei ^a   Zhao, Ruizhe ^a   Li, Shuang ^a   Cao, Qiang ^a   Li, Pu ^a   Ju, Xiaobing ^a   Lu, Qiang ^a   Li, Jie ^a   Shao, Pengfei ^a   Qin, Chao ^a   Yin, Changjun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 134; UNCLASSIFIED DRUG; KRAS PROTEIN, HUMAN; MIRN134 MICRORNA, HUMAN; ONCOPROTEIN; RAS PROTEIN;

ADULT; AGED; ARTICLE; CELL CYCLE ARREST; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MALE; ONCOGENE K RAS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; BINDING SITE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; VERY ELDERLY;

RATTUS;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BINDING SITES; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEK293 CELLS; HUMANS; KIDNEY NEOPLASMS; MALE; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RNA INTERFERENCE;

EID: 84930445331     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2014.2629     Document Type: Article

References (27)

1. Bodemann, B.O., and White, M.A. (2008). Ral gtpases and cancer: Linchpin support of the tumorigenic platform. Nat Rev Cancer 8, 133-140.
2. Buonato, J.M., and Lazzara, M.J. (2014). Erk1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to egfr inhibition. Cancer Res 74, 309-319.
3. Catto, J.W., Alcaraz, A., Bjartell, A.S., De Vere White, R., Evans, C.P., Fussel, S., Hamdy, F.C., Kallioniemi, O., Mengual, L., Schlomm, T., and Visakorpi, T. (2011). Microrna in prostate, bladder, and kidney cancer: a systematic review. Eur Urol 59, 671-681.
4. Chen, X., Guo, X., Zhang, H., Xiang, Y., Chen, J., Yin, Y., Cai, X., Wang, K., Wang, G., Ba, Y., Zhu, L., Wang, J., Yang, R., Zhang, Y., Ren, Z., Zen, K., Zhang, J., and Zhang, C.Y. (2009). Role of mir-143 targeting kras in colorectal tumorigenesis. Oncogene 28, 1385-1392.
5. Chou, J., Shahi, P., and Werb, Z. (2013). Microrna-mediated regulation of the tumor microenvironment. Cell Cycle 12, 3262-3271.
6. Croce, C.M. (2009). Causes and consequences of microrna dysregulation in cancer. Nat Rev Genet 10, 704-714.
7. Garcia, J.A., Cowey, C.L., and Godley, P.A. (2009). Renal cell carcinoma. Curr Opin Oncol 21, 266-271.
8. Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K.L., Brown, D., and Slack, F.J. (2005). Ras is regulated by the let-7 microrna family. Cell 120, 635-647.
9. Kraljevic Pavelic, S., Sedic, M., Bosnjak, H., Spaventi, S., and Pavelic, K. Metastasis. (2011). New perspectives on an old problem. Mol Cancer 10, 22.
10. Li, J., Wang, Y., Luo, J., Fu, Z., Ying, J., Yu, Y., and Yu, W. (2012). Mir-134 inhibits epithelial to mesenchymal transition by targeting foxm1 in non-small cell lung cancer cells. FEBS Lett 586, 3761-3765.
11. Liu, C.J., Shen, W.G., Peng, S.Y., Cheng, H.W., Kao, S.Y., Lin, S.C., and Chang, K.W. (2013). Mir-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting wwox gene. Int J Cancer 134, 811-821.
12. Ma, Y., Gu, Y., Zhang, Q., Han, Y., Yu, S., Lu, Z., and Chen, J. (2013). Targeted degradation of kras by an engineered ubiquitin ligase suppresses pancreatic cancer cell growth in vitro and in vivo. Mol Cancer Ther 12, 286-294.
13. Magudia, K., Lahoz, A., and Hall, A. (2012). K-ras and b-raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc. J Cell Biol 198, 185-194.
14. Ozen, M., Creighton, C.J., Ozdemir, M., and Ittmann, M. (2008). Widespread deregulation of microrna expression in human prostate cancer. Oncogene 27, 1788-1793.
15. Schubbert, S., Shannon, K., and Bollag, G. (2007). Hyperactive ras in developmental disorders and cancer. Nat Rev Cancer 7, 295-308.
16. Shin, K.H., Bae, S.D., Hong, H.S., Kim, R.H., Kang, M.K., and Park, N.H. (2011). Mir-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating k-ras. Biochem Biophys Res Commun 404, 896-902.
17. Tanaka, M., Suzuki, H.I., Shibahara, J., Kunita, A., Isagawa, T., Yoshimi, A., Kurokawa, M., Miyazono, K., Aburatani, H., Ishikawa, S., and Fukayama, M. (2013). Evi1 oncogene promotes kras pathway through suppression of microrna-96 in pancreatic carcinogenesis. Oncogene 33, 2454-2463.
18. van Spronsen, D.J., deWeijer, K.J.,Mulders, P.F., and DeMulder, P.H. (2005). Novel treatment strategies in clear-cell metastatic renal cell carcinoma. Anticancer Drugs 16, 709-717.
19. Wang, X.F., Shi, Z.M., Wang, X.R., Cao, L., Wang, Y.Y., Zhang, J.X., Yin, Y., Luo, H., Kang, C.S., Liu, N., Jiang, T., and You, Y.P. (2012). Mir-181d acts as a tumor suppressor in glioma by targeting k-ras and bcl-2. J Cancer Res Clin Oncol 138, 573-584.
20. White, N.M., Bao, T.T., Grigull, J., Youssef, Y.M., Girgis, A., Diamandis, M., Fatoohi, E., Metias, M., Honey, R.J., Stewart, R., Pace, K.T., Bjarnason, G.A., and Yousef, G.M. (2011). Mirna profiling for clear cell renal cell carcinoma: Biomarker discovery and identification of potential controls and consequences of mirna dysregulation. J Urol 186, 1077-1083.
21. Wu, W., Sun, M., Zou, G.M., and Chen, J. (2007). Microrna and cancer: current status and prospective. Int J Cancer 120, 953-960.
22. Yang, L., Parkin, D.M., Ferlay, J., Li, L., and Chen, Y. (2005). Estimates of cancer incidence in china for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14, 243-250.
23. Yi, Z., Fu, Y., Zhao, S., Zhang, X., and Ma, C. (2010). Differential expression of mirna patterns in renal cell carcinoma and nontumorous tissues. J Cancer Res Clin Oncol 136, 855-862.
24. Yu, S., Lu, Z., Liu, C., Meng, Y., Ma, Y., Zhao, W., Liu, J., Yu, J., and Chen, J. (2010). Mirna-96 suppresses kras and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res 70, 6015-6025.
25. Yuan, J.S., Reed, A., Chen, F., and Stewart, C.N., Jr. (2006). Statistical analysis of real-time pcr data. BMC Bioinform 7, 85.
26. Zhang, Y., Kim, J., Mueller, A.C., Dey, B., Yang, Y., Lee, D.H., Hachmann, J., Finderle, S., Park, D.M., Christensen, J., Schiff, D., Purow, B., Dutta, A., and Abounader, R. (2014). Multiple receptor tyrosine kinases converge on microrna-134 to control kras, stat5b, and glioblastoma. Cell Death Differ 21, 720-734.
27. Zimmerman, A.L., and Wu, S. (2011). Micrornas, cancer and cancer stem cells. Cancer Lett 300, 10-19.